A clinical research study for Systemic Sclerosis

Summary

A clinical research study to evaluating the safety and effectiveness of an
investigational drug(Anifrolumab) in study participants diagnosed with Systemic Sclerosis

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 70

Inclusion criteria:

You may be eligible to participate in this trial if you are:
- 18 to 70 years of age
- have been diagnosed with Systemic Sclerosis
Doctors will also evaluate other criteria to make sure you qualify for the study.

Exclusion criteria:

You may not be eligible to participate in this trial if you:
- have received transplantation
- have a history of malignancy
- female who is breastfeeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

Please reach out to the study team at 5878304911 or may.choi@ucalgary.ca

Principal investigator:

May Choi

Clinical trial:

Yes

REB-ID:

REB23-0918